Newsletter Subscription

Saturday, Oct 10, 2015

Engility Wins Position on $4 Bn Multi-Award Contract to Support R&D on Combating Weapons of Mass Destruction

  • Award Builds on Existing Work Engility Performs for DTRA

Engility Holdings, Inc. (NYSE:EGL), today announced that it has been selected as a prime contractor on a $4 billion multi-award contract awarded by the Defense Threat Reduction Agency (DTRA) to provide an array of technology and engineering services to support research and development for combating weapons of mass destruction.

“This win expands on work we are currently doing for DTRA under the Weapons of Mass Destruction Defeat Technology indefinite-delivery/indefinite-quantity (IDIQ) contract and we are pleased and honored by this new opportunity,” said Tony Smeraglinolo, president and CEO of Engility. “We have a long history supporting this customer on this important mission and winning a position on this new multi-award contract reflects the superior past performance and reliability our people have provided.”

Related Research on
Biosensors Market - Analysis & Forecast to 2020

The scope of R&D activity under this new IDIQ will cover a range of work, including systems engineering, systems survivability, weapons of mass destruction medical counter measures and physical counter measures. It will also cover technical nuclear forensics, nuclear detection, standoff detection, treaty and verification technologies and nuclear sensor platforms.

The contract has a five year base plus a five year option and the fee structure, which may vary by task order, is anticipated to be primarily cost-plus-fixed-fee.

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Engility Holdings, Inc.

Published on ASDNews: Dec 10, 2013


CBRNe Summit Asia

Dec 2 - 4, 2015 - Singapore, Singapore

Register More info

EAR/ITAR Boot Camp

Jan 28 - 29, 2016 - Orlando, United States

Register More info

© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs